Johnson & Johnson on mushrooming lawsuits: 'We're targets, unfortunately' - Yahoo Finance

1. Johnson & Johnson on mushrooming lawsuits: 'We're targets, unfortunately'  Yahoo Finance
2. Johnson & Johnson earnings beat expectations despite legal challenges from opioids and talc  CNBC
3. Johnson & Johnson Raises Outlook, Beats Profit Estimates  The Wall Street Journal
4. J&J (JNJ) Beats on Q3 Earnings as Sales Rise, Ups 2019 View  Yahoo Finance
5. Johnson & Johnson's bridging its $2B patent cliff gap, with help from Stelara, Darzalex  FiercePharma
6. View full coverage on Google News

Johnson & Johnson on mushrooming lawsuits: 'We're targets, unfortunately' - Yahoo Finance
Read More


Bagikan Berita Ini